Johnson & Johnson vs Main Street Capital Corporation — how do they compare? Johnson & Johnson trades at $259.01 (market cap $626.09B), while Main Street Capital Corporation trades at $59 (market cap $5.52B). The key difference: Johnson & Johnson is far larger — about 113.4× Main Street Capital Corporation's market cap, and Main Street Capital Corporation pays the higher dividend (5.39%). Which is the better fit depends on your goals.
| JNJ | MAIN | |
|---|---|---|
Market Cap | $626.09B | $5.52B |
Volume | 6,156,228 | — |
Sector | Health | Financials |
52-Week High | $267.24 | $67.54 |
52-Week Low | $172.78 | $49.63 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | 5.39% |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →